Akebia Therapeutics, Inc.
USD1.14
+0.10 (+9.62%)
CEO
John Butler
IPO Date
2014-03-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.04
Prev. Close
$1.04
Day Low
$1.03
Day High
$1.14
52W Low
$0.82
52W High
$4.08
Market Cap
$0.31B
Volume
11.58M
| $1.02 |
| 22 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | ROGERS MICHAEL W | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | ROGERS MICHAEL W | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | FRIESON RON | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | FRIESON RON | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | ZUMWALT LEANNE M | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | ZUMWALT LEANNE M | director | A-Award | Acquired | 53,600 | $1.02 |